Edition:
United States

MannKind Corp (MNKD.OQ)

MNKD.OQ on NASDAQ Stock Exchange Global Market

1.71USD
23 Apr 2018
Change (% chg)

$0.01 (+0.59%)
Prev Close
$1.70
Open
$1.67
Day's High
$1.75
Day's Low
$1.67
Volume
218,163
Avg. Vol
667,443
52-wk High
$6.96
52-wk Low
$0.67

Chart for

About

MannKind Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. Its product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic... (more)

Overall

Beta: 2.86
Market Cap(Mil.): $226.19
Shares Outstanding(Mil.): 133.05
Dividend: --
Yield (%): --

Financials

  MNKD.OQ Industry Sector
P/E (TTM): -- 185.04 32.78
EPS (TTM): -1.12 -- --
ROI: -1,957.18 -0.74 13.21
ROE: -- -2.80 15.01

BRIEF-Mannkind Announces $28.0 Million Registered Direct Offering

* MANNKIND ANNOUNCES $28.0 MILLION REGISTERED DIRECT OFFERING

Apr 06 2018

BRIEF-MannKind Restructures $79.7 Mln Debt Obligation To The Mann Group

* MANNKIND RESTRUCTURES $79.7 MILLION DEBT OBLIGATION TO THE MANN GROUP AND REDUCES PRINCIPAL OWED TO DEERFIELD BY $6.3 MILLION

Mar 12 2018

BRIEF-Mannkind Corporation Q4 Loss Per Share $0.28

* ORATION REPORTS 2017 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

Feb 27 2018

BRIEF-David Kendall Joins MannKind As Chief Medical Officer

* MANNKIND CORP - MOST RECENTLY, KENDALL SERVED AS RESEARCH PHYSICIAN AND VICE PRESIDENT OF GLOBAL MEDICAL AFFAIRS FOR LILLY DIABETES​ Source text for Eikon: Further company coverage:

Feb 06 2018

BRIEF-Mannkind, On Jan 18, Co, Unit Entered Into Exchange, Sixth Amendment To Facility Agreement With Deerfield

* MANNKIND - ‍ ON JAN 18, CO AND UNIT ENTERED INTO AN EXCHANGE AND SIXTH AMENDMENT TO FACILITY AGREEMENT WITH DEERFIELD - SEC FILING​

Jan 19 2018

BRIEF-Mannkind Q3 loss per share $0.31

* Mannkind Corporation reports 2017 third quarter financial results

Nov 07 2017

Competitors

  Price Chg
Novo Nordisk A/S (NOVOb.CO) kr.285.20 +1.00
Pfizer Inc. (PFE.N) $36.80 +0.17
Sanofi SA (SASY.PA) €65.71 +0.43
Eli Lilly And Co (LLY.N) $80.20 +1.14
Nektar Therapeutics (NKTR.OQ) $85.45 -0.76
Albireo Pharma Inc (ALBO.OQ) $32.98 -0.29

Earnings vs. Estimates